This is a preprint.
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution
- PMID: 40162213
- PMCID: PMC11952669
- DOI: 10.21203/rs.3.rs-6097445/v1
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution
Update in
-
HKU25 clade MERS-related coronaviruses use ACE2 as a functional receptor.Nat Microbiol. 2025 Nov;10(11):2860-2874. doi: 10.1038/s41564-025-02152-y. Epub 2025 Oct 30. Nat Microbiol. 2025. PMID: 41168429 Free PMC article.
Abstract
Dipeptidyl peptidase-4 (DPP4) is a well-established receptor for several MERS-related coronaviruses (MERSr-CoVs) isolated from humans, camels, pangolins, and bats 1-6. However, the receptor usage of many genetically diverse bat MERSr-CoVs with broad geographical distributions remains poorly understood. Recent studies have identified angiotensin-converting enzyme 2 (ACE2) as an entry receptor for multiple merbecovirus clades. Here, using viral antigen and pseudovirus-based functional assays, we demonstrate that several bat merbecoviruses from the HKU25 clade previously thought to utilize DPP4 7, employ ACE2 as their functional receptor. Cryo-electron microscopy analysis revealed that HsItaly2011 and VsCoV-a7 recognize ACE2 with a binding mode sharing similarity with that of HKU5 but involving remodeled interfaces and distinct ortholog selectivity, suggesting a common evolutionary origin of ACE2 utilization for these two clades of viruses. EjCoV-3, a strain closely related to the DPP4-using MERSr-CoV BtCoV-422, exhibited relatively broad ACE2 ortholog tropism and could utilize human ACE2 albeit suboptimally. Despite differences in entry mechanisms and spike proteolytic activation compared to MERS-CoV, these viruses remain sensitive to several broadly neutralizing antibodies and entry inhibitors. These findings redefine our understanding of the evolution of receptor usage among MERSr-CoVs and highlight the versatility of ACE2 as a functional receptor for diverse coronaviruses.
Keywords: ACE2; Cryo-EM; DPP4; EjCoV-3; HKU25; MERSr-CoV; Receptor.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
